Screening HLA to Prevent Severe Drug Reactions-A Devil's Advocate Perspective.
作者信息
Divito Sherrie J
机构信息
Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
出版信息
JAMA Dermatol. 2019 Jun 1;155(6):655-656. doi: 10.1001/jamadermatol.2018.5336.
Abstract
摘要
相似文献
1
Screening HLA to Prevent Severe Drug Reactions-A Devil's Advocate Perspective.筛查人类白细胞抗原以预防严重药物不良反应——一个反对者的观点
JAMA Dermatol. 2019 Jun 1;155(6):655-656. doi: 10.1001/jamadermatol.2018.5336.
2
Association between HLA-B*1301 and dapsone-induced hypersensitivity reactions among leprosy patients in China.中国麻风病患者中HLA - B*1301与氨苯砜引起的超敏反应之间的关联
J Invest Dermatol. 2013 Nov;133(11):2642-2644. doi: 10.1038/jid.2013.192. Epub 2013 May 19.
3
HLA-B*13:01 and the dapsone hypersensitivity syndrome.HLA-B*13:01 与氨苯砜超敏反应综合征。
N Engl J Med. 2013 Oct 24;369(17):1620-8. doi: 10.1056/NEJMoa1213096.
4
Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population.氨苯砜引起的严重皮肤药物不良反应与泰国人群中的HLA - B*13:01等位基因密切相关。
Pharmacogenet Genomics. 2017 Dec;27(12):429-437. doi: 10.1097/FPC.0000000000000306.
5
The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions.HLA-B*13:01 等位基因在氨苯砜诱导的严重皮肤不良反应发病机制中的作用。
J Invest Dermatol. 2018 Jul;138(7):1546-1554. doi: 10.1016/j.jid.2018.02.004. Epub 2018 Feb 17.
6
HLA Screening for Dapsone Hypersensitivity in India-A Long Way Ahead.印度对氨苯砜超敏反应进行HLA筛查——任重道远。
JAMA Dermatol. 2019 Dec 1;155(12):1428-1429. doi: 10.1001/jamadermatol.2019.3169.
7
HLA Screening for Dapsone Hypersensitivity in India-A Long Way Ahead-In Reply.印度对氨苯砜超敏反应的HLA筛查——任重道远——回应
JAMA Dermatol. 2019 Dec 1;155(12):1429. doi: 10.1001/jamadermatol.2019.2609.
8
Detecting true and false opinions: The Devil's Advocate approach as a lie detection aid.辨别真假观点：以唱反调的方式辅助测谎
Acta Psychol (Amst). 2010 Jul;134(3):323-9. doi: 10.1016/j.actpsy.2010.03.005. Epub 2010 Apr 15.
9
A docking model of dapsone bound to HLA-B*13:01 explains the risk of dapsone hypersensitivity syndrome.与 HLA-B*13:01 结合的氨苯砜对接模型解释了氨苯砜过敏综合征的风险。
J Dermatol Sci. 2017 Dec;88(3):320-329. doi: 10.1016/j.jdermsci.2017.08.007. Epub 2017 Aug 24.
10
Amino Acid Variants of HLA-DRB1 Confer Susceptibility to Dapsone Hypersensitivity Syndrome in Addition to HLA-B*13:01.除 HLA-B*13:01 外，HLA-DRB1 氨基酸变异也与氨苯砜超敏综合征易感性相关。
J Invest Dermatol. 2018 May;138(5):1101-1106. doi: 10.1016/j.jid.2017.11.027. Epub 2017 Dec 9.
引用本文的文献
1
Attribution of causality in Stevens-Johnson syndrome/toxic epidermal necrolysis.史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症的因果关系归因
Ocul Surf. 2025 Jun 18;38:104-112. doi: 10.1016/j.jtos.2025.06.004.
2
Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.评估史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症中需改进致敏药物鉴别的必要性。
JAMA Dermatol. 2023 Aug 1;159(8):830-836. doi: 10.1001/jamadermatol.2023.1693.
本文引用的文献
1
Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy.评估 HLA-B*13:01 前瞻性筛查在预防麻风病患者中发生氨苯砜超敏综合征中的作用。
JAMA Dermatol. 2019 Jun 1;155(6):666-672. doi: 10.1001/jamadermatol.2018.5360.
2
Life-threatening dermatoses: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Impact on the Spanish public health system (2010-2015).危及生命的皮肤病：史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症。对西班牙公共卫生系统的影响（2010-2015 年）。
PLoS One. 2018 Jun 18;13(6):e0198582. doi: 10.1371/journal.pone.0198582. eCollection 2018.
3
Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via Pharmacogenomics.药物性史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症需要通过药物基因组学进行最佳患者分层和治疗诊断。
Annu Rev Genomics Hum Genet. 2018 Aug 31;19:329-353. doi: 10.1146/annurev-genom-083115-022324. Epub 2018 Apr 13.
4
Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis.HLA-B*1301 与氨苯砜诱导的皮肤不良反应的关联：系统评价和荟萃分析。
JAMA Dermatol. 2018 Apr 1;154(4):441-446. doi: 10.1001/jamadermatol.2017.6484.
5
A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions.一种用于检测 HLA-A*31:01/HLA-B*15:02 等位基因的新型多重聚合酶链反应检测方法，该等位基因与卡马西平诱导的严重皮肤不良反应易感性相关。
HLA. 2017 Dec;90(6):335-342. doi: 10.1111/tan.13143. Epub 2017 Oct 2.
6
Is universal HLA-B*15:02 screening a cost-effective option in an ethnically diverse population? A case study of Malaysia.在一个种族多样化的人群中，进行普遍的 HLA-B*15:02 筛查是否具有成本效益？以马来西亚为例的案例研究。
Br J Dermatol. 2017 Oct;177(4):1102-1112. doi: 10.1111/bjd.15498. Epub 2017 Sep 21.
7
HLA and Delayed Drug-Induced Hypersensitivity.人类白细胞抗原与药物迟发型超敏反应
Int Arch Allergy Immunol. 2016;170(3):163-79. doi: 10.1159/000448217. Epub 2016 Aug 26.
8
Next-Generation Sequencing of the HLA locus: Methods and impacts on HLA typing, population genetics and disease association studies.人类白细胞抗原（HLA）基因座的新一代测序：方法及其对HLA分型、群体遗传学和疾病关联研究的影响
Hum Immunol. 2016 Nov;77(11):1016-1023. doi: 10.1016/j.humimm.2016.04.002. Epub 2016 Apr 5.
9
Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults.美国成年人史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的发病率与死亡率
J Invest Dermatol. 2016 Jul;136(7):1387-1397. doi: 10.1016/j.jid.2016.03.023. Epub 2016 Mar 30.
10
T cell-mediated hypersensitivity reactions to drugs.药物引起的T细胞介导的超敏反应。
Annu Rev Med. 2015;66:439-54. doi: 10.1146/annurev-med-050913-022745. Epub 2014 Oct 27.
Zotero 插件